版本:
中国

BRIEF-Proteon Therapeutics qtrly net loss per share attributable to common stockholders $0.39

May 10 Proteon Therapeutics Inc:

* Proteon Therapeutics announces first quarter 2017 financial results

* Qtrly net loss per share attributable to common stockholders $0.39

* Proteon Therapeutics - expects its cash, cash equivalents and available-for-sale investments will be sufficient to fund its operations into Q3 of 2018. Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐